Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1196 studies found for:    GLP-1
Show Display Options
Rank Status Study
1 Recruiting Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting
Conditions: Right Coronary Artery Percutaneous Coronary Intervention;   Right Ventricular Diastolic Dysfunction
Interventions: Procedure: Right Coronary Artery Percutaneous Coronary Intervention;   Other: saline placebo infusion;   Other: GLP-1 Infusion
2 Completed Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans
Condition: Hyperglycemia
Interventions: Drug: GLP-1 control;   Drug: GLP-1 and Exendin(9-39) 300;   Drug: saline control;   Drug: GLP-1 and Exendin(9-39) 600;   Drug: GLP-1 and Exendin(9-39) 900;   Drug: GLP-1 and Exendin(9-39) 1200
3 Unknown  GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Condition: Healthy
Interventions: Other: 1,5 nmol/kg,GLP-1 sc injection;   Other: 1,5 nmol/kg GLP-1 9-36amide, sc injection;   Other: Exendin-4 ;10 ug,sc injection;   Other: saline
4 Completed Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
Conditions: Diabetes Mellitus Type 2;   Hyperglycemia
Interventions: Drug: GLP-1;   Drug: Human regular insulin intravenously
5 Recruiting GLP-1 Loading During Elective Percutaneous Coronary Intervention
Conditions: Angina Pectoris;   Myocardial Infarction;   Reperfusion Injury;   Coronary Heart Disease
Interventions: Drug: GLP-1;   Drug: placebo
6 Recruiting GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
Condition: Functional Gastrointestinal Disorders
Interventions: Biological: GLP-1;   Biological: Intravenous saline
7 Completed
Has Results
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
Conditions: Type 2 Diabetes Mellitus;   Healthy
Interventions: Drug: GLP-1 Low Dose;   Drug: GLP-1 Mid-Range Dose;   Drug: GLP-1 High Dose;   Drug: Saline
8 Unknown  The Microvascular Function of GLP-1 and Its Analogues
Conditions: Type 2 Diabetes;   Obesity
Interventions: Drug: GLP-1;   Drug: Placebo
9 Completed GLP-1 Infusion and Long-Time Fasting
Condition: Type 2 Diabetes
Interventions: Drug: Glucagon-like-peptide-1 (7-36) amide;   Drug: Placebo
10 Unknown  Effect of GLP-1 on Postprandial Lipid Metabolism
Condition: Heart Disease
Interventions: Drug: Exendin-9;   Drug: GLP-1;   Other: saline
11 Recruiting Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Condition: GLP-1;Metformin;Telomere-telomerase System;Par-4
Interventions: Drug: Liraglutide;   Drug: Metformin
12 Enrolling by invitation Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle
Condition: Sarcopenia
Interventions: Drug: GLP-1;   Drug: Insulin Actrapid;   Dietary Supplement: Oral amino acids;   Drug: GIP;   Drug: Intravenous amino acids
13 Unknown  Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery
Condition: CABG
Interventions: Drug: Placebo;   Drug: GLP-1 (7-36) amide
14 Recruiting GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake
Conditions: Obesity;   Adiposity;   Type 2 Diabetes
Interventions: Other: GIP;   Other: GLP-1;   Other: NaCl (placebo)
15 Completed Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
Condition: Healthy
Intervention: Drug: native glp-1 (7-36)
16 Completed Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
Condition: Hypoglycaemia
Interventions: Drug: GLP-1;   Drug: Placebo (Saline);   Drug: TNF-alfa;   Other: OGTT;   Other: IVGTT
17 Recruiting GLP-1 and Hypoglycemia
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Glucagon-Like Peptide- 1 (GLP-1) infusion;   Other: Placebo Comparator: Saline Infusion
18 Completed GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose
Conditions: Physiology;   Gastroenterology;   Endocrinology
Intervention: Other: Glucose-insulinotropic peptide, Glucagon-like peptide-1
19 Terminated GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage (ICH)
Intervention: Drug: GLP-1 CellBeads
20 Completed GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
Condition: Type 2 Diabetes Mellitus
Intervention: Biological: Glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years